Description: PolarityTE Inc is a commercial-stage biotechnology and regenerative biomaterials company. Its focused on transforming the lives of patients by discovering, designing and developing regenerative tissue products and biomaterials.
Home Page: www.polarityte.com
PTE Technical Analysis
1960 South 4250 West
Salt Lake City,
UT
84104
United States
Phone:
800 560 3983
Officers
| Name | Title |
|---|---|
| Mr. Richard Hague | Pres & CEO |
| Mr. Jacob Alexander Patterson | Chief Financial Officer |
| Mr. Nikolai Sopko | Chief Scientific Officer and VP of R&D |
| Mr. Rich Haerle | VP of Investor Relations & Strategy |
| Mr. Mark E. Lehman J.D. | Chief Legal Officer |
| Angela Ziegler | VP of Marketing & PR |
| Mr. Alain Adam | VP of Sales |
| Dr. Stephen Milner M.D., DDS, DSc, FRCSE, FACS | Chief Clinical Officer & Member of Clinical Advisory Board |
| Dr. Jon Anthony Joseph Burrows B.Sc., M.Sc., Ph.D. | Sr. VP of Corp. Devel. & Pres of Contract Services |
| Mr. Ryan Mathis M.D. | Chief Medical Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.2948 |
| Price-to-Sales TTM: | 2.7772 |
| IPO Date: | 1999-08-13 |
| Fiscal Year End: | December |
| Full Time Employees: | 59 |